Literature DB >> 15194747

A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis.

Yee-Joo Tan1, Eileen Teng, Shuo Shen, Timothy H P Tan, Phuay-Yee Goh, Burtram C Fielding, Eng-Eong Ooi, Hwee-Cheng Tan, Seng Gee Lim, Wanjin Hong.   

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) genome contains open reading frames (ORFs) that encode for several genes that are homologous to proteins found in all known coronaviruses. These are the replicase gene 1a/1b and the four structural proteins, nucleocapsid (N), spike (S), membrane (M), and envelope (E), and these proteins are expected to be essential for the replication of the virus. In addition, this genome also contains nine other potential ORFs varying in length from 39 to 274 amino acids. The largest among these is the first ORF of the second longest subgenomic RNA, and this protein (termed U274 in the present study) consists of 274 amino acids and contains three putative transmembrane domains. Using antibody specific for the C terminus of U274, we show U274 to be expressed in SARS-CoV-infected Vero E6 cells and, in addition to the full-length protein, two other processed forms were also detected. By indirect immunofluorescence, U274 was localized to the perinuclear region, as well as to the plasma membrane, in both transfected and infected cells. Using an N terminus myc-tagged U274, the topology of U274 and its expression on the cell surface were confirmed. Deletion of a cytoplasmic domain of U274, which contains Yxxphi and diacidic motifs, abolished its transport to the cell surface. In addition, U274 expressed on the cell surface can internalize antibodies from the culture medium into the cells. Coimmunoprecipitation experiments also showed that U274 could interact specifically with the M, E, and S structural proteins, as well as with U122, another protein that is unique to SARS-CoV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194747      PMCID: PMC421683          DOI: 10.1128/JVI.78.13.6723-6734.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Efficient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine-based and di-acidic motifs.

Authors:  C S Sevier; O A Weisz; M Davis; C E Machamer
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  A di-acidic signal required for selective export from the endoplasmic reticulum.

Authors:  N Nishimura; W E Balch
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

Review 4.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

5.  Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity.

Authors:  B H Tan; J Fu; R J Sugrue; E H Yap; Y C Chan; Y H Tan
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

6.  Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes.

Authors:  P Baudoux; C Carrat; L Besnardeau; B Charley; H Laude
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host.

Authors:  Cornelis A M de Haan; Paul S Masters; Xiaolan Shen; Susan Weiss; Peter J M Rottier
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

8.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

9.  Genomic organization and expression of the 3' end of the canine and feline enteric coronaviruses.

Authors:  H Vennema; J W Rossen; J Wesseling; M C Horzinek; P J Rottier
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

10.  Early events of SARS coronavirus infection in vero cells.

Authors:  M L Ng; S H Tan; E E See; E E Ooi; A E Ling
Journal:  J Med Virol       Date:  2003-11       Impact factor: 2.327

View more
  94 in total

1.  Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.

Authors:  Fusheng Si; Bingqing Chen; Xiaoxia Hu; Ruisong Yu; Shijuan Dong; Ruiyang Wang; Zhen Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway.

Authors:  Yee-Joo Tan; Burtram C Fielding; Phuay-Yee Goh; Shuo Shen; Timothy H P Tan; Seng Gee Lim; Wanjin Hong
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein.

Authors:  Naoto Ito; Eric C Mossel; Krishna Narayanan; Vsevolod L Popov; Cheng Huang; Taisuke Inoue; Clarence J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells.

Authors:  Cheng Huang; Krishna Narayanan; Naoto Ito; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein.

Authors:  Cheng Huang; Naoto Ito; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase.

Authors:  Sarah A Kopecky-Bromberg; Luis Martinez-Sobrido; Peter Palese
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex.

Authors:  Scott R Schaecher; Michael S Diamond; Andrew Pekosz
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

8.  A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus.

Authors:  Lecia Pewe; Haixia Zhou; Jason Netland; Chandra Tangudu; Heidi Olivares; Lei Shi; Dwight Look; Thomas Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1.

Authors:  Nur Khairiah Mohd-Ismail; Lin Deng; Sunil Kumar Sukumaran; Victor C Yu; Hak Hotta; Yee-Joo Tan
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.